Candel Therapeutics Announces Pricing of Public Offering
Portfolio Pulse from
Candel Therapeutics has announced the pricing of a public offering, selling 10,000,001 shares at $6.00 each and pre-funded warrants for 3,333,333 shares at $5.99 each. The offering is expected to raise approximately $80 million, with a closing date around December 16, 2024.
December 13, 2024 | 4:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Candel Therapeutics is conducting a public offering of 10 million shares at $6.00 each, with additional pre-funded warrants, aiming to raise $80 million. This could lead to stock price volatility.
The public offering increases the number of shares available, which can dilute existing shares and potentially lead to a decrease in stock price. The offering's success and market reaction will influence short-term price movements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100